Medication info
Candesartan Cilexetil Tablet 8 mg

Candesartan Cilexetil Tablet 8 mg

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
Pale pink, convex, round tablet on both sides
Packaging
30 tablets/bottle. 100 tablets/bottle
Approval status
Active

MFDS item code 201100215 · Approved 2011.01.14 · Insurance code 642403160

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is candesartan cilexetil 8 ∼ 16 mg orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No initial dose adjustment is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No initial dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension. It can also be safely used in patients with heart failure who have impaired left ventricular systolic function and require combination therapy with ACE inhibitors or those who are intolerant to ACE inhibitors. This helps relieve the strain on the heart and improve symptoms. Therefore, it is effectively used in the treatment of hypertension and certain patients with heart failure.

How to take

Adult dose

Take this medicine at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is candesartan cilexetil 8 ∼ 16 mg orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No initial dose adjustment is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No initial dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This drug can cause serious harm to the fetus, especially if taken in the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Pregnant or nursing women, as well as individuals allergic to this drug or its ingredients, should not take it. It is also safer not to use this drug in patients with severe liver impairment or a history of angioedema. Elderly patients, those with hyperkalemia, mildly impaired liver function, or those with heart valve disease or cardiovascular disease should use this medication with special caution. Common side effects may include dizziness, back pain, and upper respiratory infections; however, these are generally mild and transient. Regular blood tests are recommended for heart failure patients as side effects such as low blood pressure, hyperkalemia, and reduced kidney function may occur. Patients with poor kidney function should be closely monitored for blood tests and physical condition, as there is a risk of blood pressure dropping too low or kidney function worsening. When taking this drug with other antihypertensive medications, careful dose adjustments and patient status checks are necessary as blood pressure may decrease too much. Particular caution should be taken when used with diuretics, potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs, as the risk of side effects may increase due to interactions. Women who are pregnant or planning to become pregnant should not take this drug, and nursing women are also advised to avoid it. The safety and efficacy in children and adolescents under 18 years of age have not been established, and use is not recommended. In case of overdose, symptoms such as dizziness, low blood pressure, and tachycardia may occur, and appropriate medical care should be sought as needed. This drug should be kept out of reach of children, and it is safest not to transfer it to another container. Caution is required when driving or operating machinery, as dizziness may occur.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory abnormalities
  • dyspepsia
Show 50 more
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • nausea
  • diarrhea
  • increased liver enzyme levels
  • hepatitis
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • arthralgia
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • memory loss
  • appetite loss
  • increased appetite
  • tinnitus
  • altered taste
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the drug.

Appearance and packaging

Appearance

Pale pink, convex, round tablet on both sides

Package unit

30 tablets/bottle. 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.